Keywords: switzerland, first, approve, novartis, tasigna, become, nation

Switzerland is first to approve Novartis' Tasigna

Article | 30 July 2007

Print This

Switzerland has become the first nation to approve Novartis' Tasigna (nilotinib) for patients with chronic myeloid leukemia who are resistant ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in